Andere Kunden interessierten sich auch für
![A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration]( "A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration")
A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration53,99 €![Risk Assessment in the Federal Government]( "Risk Assessment in the Federal Government")
Risk Assessment in the Federal Government39,99 €![Army Sanitary Administration and Its Reform Under the Late Lord Herbert.: Read at the London Meeting of the]( "Army Sanitary Administration and Its Reform Under the Late Lord Herbert.: Read at the London Meeting of the")
Army Sanitary Administration and Its Reform Under the Late Lord Herbert.: Read at the London Meeting of the "Congrès De Bienfaisance," June, 186215,99 €![Stakeholder Perspectives on a Culture of Health]( "Stakeholder Perspectives on a Culture of Health")
Stakeholder Perspectives on a Culture of Health25,99 €![The Licensing Exam Review Guide in Nursing Home Administration]( "The Licensing Exam Review Guide in Nursing Home Administration")
The Licensing Exam Review Guide in Nursing Home Administration99,99 €![Cultural Competency for Health Administration and Public Health]( "Cultural Competency for Health Administration and Public Health")
Cultural Competency for Health Administration and Public Health96,99 €![GIS in Public Health Practice]( "GIS in Public Health Practice")
GIS in Public Health Practice90,99 €
Like many other agencies of the federal government, the Food and Drug Administration (FDA) relies extensively on external advisory committees for independent scientific and technical advice. Recognizing that the existing advisory committee system is essentially sound, this volume recommends ways of enhancing the use of these committees in the evaluation of drugs, biological materials, and medical devices; strengthening the agency's management of the system; and increasing the accountability of the system to the public. In doing so, it examines and makes recommendations on such issues as the recruitment of committee members, the FDA's management of financial conflict of interest and intellectual bias among members, and the operations and management of the advisory committee system.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.